Skip to main content

Zovighian Bernard J's Form 4 filing

Edwards Lifesciences Corp (EW) · filed May 12, 2026

Accession no.
0001225208-26-005172
Filed
May 12, 2026
Trade date
May 11-12, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.83M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zovighian Bernard JCIK 0001665141Director, Officer (CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2026Common StockMOption exerciseAcquired+47,207$0.00$0157,491.65Direct
May 11, 2026Common StockFTax withholdingDisposed−26,198$79.96−$2,094,792.08125,804.65Direct
May 12, 2026Common StockGGiftDisposed−26,640$0.00$099,164.65Direct
May 12, 2026Common StockGGiftAcquired+26,640$0.00$048,390.55Indirect
May 12, 2026Common StockSSaleDisposed−845$78.40−$66,24847,545.55Indirect
May 12, 2026Common StockSSaleDisposed−35,506$77.92−$2,766,627.5212,039.55Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 11, 2026Common StockMOption exerciseDisposed−47,207$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)